Mangoceuticals announced that it will conduct a reverse stock split of its outstanding shares of common stock at a ratio of 1-for-15. The Reverse Stock Split will become effective on October 16, 2024 at 12:01 a.m. Eastern Time, with shares expected to begin trading on the Nasdaq Capital Market, on a split-adjusted basis, at market open on October 16, 2024. In connection with the Reverse Stock Split, every fifteen shares of the company’s common stock issued and outstanding as of the Effective Time will be automatically converted into one share of the company’s common stock. No change will be made to the trading symbol for the company’s shares of common stock, “MGRX“, in connection with the reverse split.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

See the top stocks recommended by analysts >>

Read More on MGRX:

• Mangoceuticals releases oral Tirzepatide tablet for weight loss

• Mangoceuticals launches oral semaglutide for advanced weight loss treatment

• Mangoceuticals Raises Capital and Boosts CEO Perks

• Mangoceuticals files 16.17M shares of common stock for holders

• Mangoceuticals reports 1H revenue $377,258 vs. $241,959 last year